Semglee (Insulin glargine-yfgn) is a long-acting type of insulin used to treat type 1 and type 2 diabetes. Semglee is a biosimilar for lantus (insulin glargine). Biosimilars are biologic drugs that are similar to the original medication with no meaningful differences in effectiveness or safety. Semglee may be covered by your Medicare or insurance plan, but some pharmacy coupons or cash prices could help offset the cost.

With the Patient Assistance Program from Viatris, receive your prescription at no charge if you are eligible.